cached image

Richard A. Glennon - Publications

Affiliations: 
Medicinal Chemistry Virginia Commonwealth University, Richmond, VA, United States 
Website:
http://www.pharmacy.vcu.edu/sub/faculty/facdetail.aspx?id=55

279 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Davies RA, Baird TR, Nguyen VT, Ruiz B, Sakloth F, Eltit JM, Negus SS, Glennon RA. An investigation of the optical isomers of methcathinone (MCAT), and two achiral analogs, at monoamine transporters and in intracranial self- stimulation studies in rats. Acs Chemical Neuroscience. PMID 32356961 DOI: 10.1021/acschemneuro.9b00617  0.48
2019 Shah UH, Gaitonde SA, Moreno JL, Glennon RA, Dukat M, González-Maeso J. A revised pharmacophore model for 5-HT2A receptor antagonists derived from the atypical antipsychotic agent risperidone. Acs Chemical Neuroscience. PMID 30609893 DOI: 10.1021/acschemneuro.8b00637  0.64
2018 Walther D, Shalabi AR, Baumann MH, Glennon RA. Systematic structure-activity studies on selected 2-, 3-, and 4-monosubstituted synthetic methcathinone analogs as monoamine transporter releasing agents. Acs Chemical Neuroscience. PMID 30354055 DOI: 10.1021/acschemneuro.8b00524  0.48
2018 Dukat M, Jain AD, German N, Ferrara-Pontoriero R, Huang Y, Ma Y, Schulte MK, Glennon RA. des-Formylflustrabromine (dFBr): A Structure-Activity Study on its Ability to Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors. Acs Chemical Neuroscience. PMID 30028943 DOI: 10.1021/acschemneuro.8b00156  0.64
2018 Battisti UM, Sitta R, Harris A, Sakloth F, Walther D, Ruchala I, Negus S, Baumann MH, Glennon RA, Eltit JM. Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior. Acs Chemical Neuroscience. PMID 29697951 DOI: 10.1021/acschemneuro.8b00138  0.48
2017 Glennon RA, Dukat M. Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences. Annals of Forensic Research and Analysis. 4. PMID 30288398  0.64
2017 Solis E, Partilla JS, Sakloth F, Ruchala I, Schwienteck KL, De Felice LJ, Eltit JM, Glennon RA, Negus SS, Baumann MH. N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28530234 DOI: 10.1038/npp.2017.98  0.48
2017 Shalabi AR, Walther D, Baumann MH, Glennon RA. Deconstructed analogs of bupropion reveal structural requirements for transporter inhibition versus substrate-induced neurotransmitter release. Acs Chemical Neuroscience. PMID 28220701 DOI: 10.1021/acschemneuro.7b00055  0.48
2016 Glennon RA, Dukat M. Structure-Activity Relationships of Synthetic Cathinones. Current Topics in Behavioral Neurosciences. PMID 27830576 DOI: 10.1007/7854_2016_41  0.64
2016 Younkin J, Gaitonde SA, Ellaithy A, Vekariya RH, Baki L, Moreno JL, Shah S, Drossopoulos P, Hideshima KS, Eltit JM, González-Maeso J, Logothetis DE, Dukat M, Glennon RA. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists. Acs Chemical Neuroscience. PMID 27385190 DOI: 10.1021/acschemneuro.6b00162  1
2016 Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Brain Research Bulletin. PMID 27142261 DOI: 10.1016/j.brainresbull.2016.04.011  0.76
2016 Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin. The Journal of Pharmacology and Experimental Therapeutics. 356: 182-90. PMID 26645638 DOI: 10.1124/jpet.115.229559  0.56
2015 Hutsell BA, Baumann MH, Partilla JS, Banks ML, Vekariya R, Glennon RA, Negus SS. Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26738428 DOI: 10.1016/j.euroneuro.2015.12.010  0.48
2015 May JA, Sharif NA, McLaughlin MA, Chen HH, Severns BS, Kelly CR, Holt WF, Young R, Glennon RA, Hellberg MR, Dean TR. Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor Agonist. Journal of Medicinal Chemistry. PMID 26551970 DOI: 10.1021/acs.jmedchem.5b00857  0.76
2015 Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine. Bioorganic & Medicinal Chemistry. 23: 5574-9. PMID 26233799 DOI: 10.1016/j.bmc.2015.07.035  0.48
2015 Kolanos R, Sakloth F, Jain AD, Partilla JS, Baumann MH, Glennon RA. Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters. Acs Chemical Neuroscience. PMID 26217965 DOI: 10.1021/acschemneuro.5b00160  1
2015 Hamouda AK, Wang ZJ, Stewart DS, Jain AD, Glennon RA, Cohen JB. Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. Molecular Pharmacology. 88: 1-11. PMID 25870334 DOI: 10.1124/mol.115.098913  0.48
2015 Kolanos R, Partilla JS, Baumann MH, Hutsell BA, Banks ML, Negus SS, Glennon RA. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats. Acs Chemical Neuroscience. 6: 771-7. PMID 25688761 DOI: 10.1021/acschemneuro.5b00006  1
2015 Tang QY, Kolanos R, De Felice LJ, Glennon RA. Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter. Acs Chemical Neuroscience. 6: 551-8. PMID 25594379 DOI: 10.1021/cn500282f  1
2015 Sakloth F, Kolanos R, Mosier PD, Bonano JS, Banks ML, Partilla JS, Baumann MH, Negus SS, Glennon RA. Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. British Journal of Pharmacology. 172: 2210-8. PMID 25522019 DOI: 10.1111/bph.13043  1
2015 Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML, Glennon RA, Cozzi NV, Partilla JS, Baumann MH, Negus SS. Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. British Journal of Pharmacology. 172: 2433-44. PMID 25438806 DOI: 10.1111/bph.13030  1
2015 Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine Bioorganic and Medicinal Chemistry. DOI: 10.1016/j.bmc.2015.07.035  1
2014 Bonano JS, Runyon SP, Hassler C, Glennon RA, Stevens Negus S. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats. European Journal of Pharmacology. 743: 98-105. PMID 25220242 DOI: 10.1016/j.ejphar.2014.09.006  0.4
2014 Rao BK, Samanta D, Joshi S, Basu K, Baldwin SD, Jha A, Dukat M, Glennon RA, Jena P. Receptor-ligand interaction at 5-HT3 serotonin receptors: a cluster approach. The Journal of Physical Chemistry. A. 118: 8471-6. PMID 24878072 DOI: 10.1021/jp5017906  1
2014 Ruchala I, Cabra V, Solis E, Glennon RA, De Felice LJ, Eltit JM. Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels. Cell Calcium. 56: 25-33. PMID 24854234 DOI: 10.1016/j.ceca.2014.04.003  1
2014 Glennon RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Advances in Pharmacology (San Diego, Calif.). 69: 581-620. PMID 24484988 DOI: 10.1016/B978-0-12-420118-7.00015-9  1
2014 De Felice LJ, Glennon RA, Negus SS. Synthetic cathinones: Chemical phylogeny, physiology, and neuropharmacology Life Sciences. 97: 20-26. PMID 24231923 DOI: 10.1016/j.lfs.2013.10.029  1
2014 Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS. Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology. 231: 199-207. PMID 23949206 DOI: 10.1007/s00213-013-3223-5  1
2014 Bonano JS, Runyon SP, Hassler C, Glennon RA, Stevens Negus S. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats European Journal of Pharmacology. 743: 98-105. DOI: 10.1016/j.ejphar.2014.09.006  1
2014 Glennon RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention Advances in Pharmacology. 69: 583-620. DOI: 10.1016/B978-0-12-420118-7.00015-9  1
2013 Kolanos R, Solis E, Sakloth F, De Felice LJ, Glennon RA. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. Acs Chemical Neuroscience. 4: 1524-9. PMID 24116392 DOI: 10.1021/cn4001236  1
2013 Cameron K, Kolanos R, Verkariya R, De Felice L, Glennon RA. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter Psychopharmacology. 227: 493-499. PMID 23371489 DOI: 10.1007/s00213-013-2967-2  1
2013 Cameron KN, Kolanos R, Solis E, Glennon RA, De Felice LJ. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. British Journal of Pharmacology. 168: 1750-7. PMID 23170765 DOI: 10.1111/bph.12061  1
2011 German N, Kim JS, Jain A, Dukat M, Pandya A, Ma Y, Weltzin M, Schulte MK, Glennon RA. Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine Journal of Medicinal Chemistry. 54: 7259-7267. PMID 21905680 DOI: 10.1021/jm200834x  1
2011 Zhang X, Andren PE, Glennon RA, Svenningsson P. Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. The Journal of Comparative Neurology. 519: 1816-27. PMID 21452237 DOI: 10.1002/cne.22605  1
2011 Klein MT, Dukat M, Glennon RA, Teitler M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. The Journal of Pharmacology and Experimental Therapeutics. 337: 860-7. PMID 21422162 DOI: 10.1124/jpet.111.179606  1
2011 Glennon RA, Young R. Drug Discrimination and Development of Novel Agents and Pharmacological Tools Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 217-233. DOI: 10.1002/9781118023150.ch7  1
2011 Glennon RA, Young R. Drug Discrimination and Mechanisms of Drug Action Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 183-216. DOI: 10.1002/9781118023150.ch6  1
2011 Glennon RA, Young R. Drug Discrimination and In Vivo Structure-Activity Relationships Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 163-181. DOI: 10.1002/9781118023150.ch5  1
2011 Glennon RA, Young R. Role of Stereochemistry in Drug Discrimination Studies Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 129-161. DOI: 10.1002/9781118023150.ch4  1
2011 Glennon RA, Young R. Drug Discrimination: Practical Considerations Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 41-128. DOI: 10.1002/9781118023150.ch3  1
2011 Glennon RA, Young R. Methodological Considerations Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 19-40. DOI: 10.1002/9781118023150.ch2  1
2011 Glennon RA, Young R. An Introduction to Drug Discrimination Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 3-17. DOI: 10.1002/9781118023150.ch1  1
2011 Glennon RA, Young R. Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. DOI: 10.1002/9781118023150  1
2010 Dukat M, Wesolowska A, Alley G, Young S, Abdrakhmanova GR, Navarro HA, Young R, Glennon RA. MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay Psychopharmacology. 210: 547-557. PMID 20431995 DOI: 10.1007/s00213-010-1857-0  1
2010 Glennon RA, Siripurapu U, Roth BL, Kolanos R, Bondarev ML, Sikazwe D, Lee M, Dukat M. The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs. Current Topics in Medicinal Chemistry. 10: 579-95. PMID 20166945 DOI: 10.2174/156802610791111542  1
2010 Giorgioni G, Claudi F, Ruggieri S, Ricciutelli M, Palmieri GF, Stefano AD, Sozio P, Cerasa LS, Chiavaroli A, Ferrante C, Orlando G, Glennon RA. Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as l-DOPA prodrugs Bioorganic and Medicinal Chemistry. 18: 1834-1843. PMID 20153654 DOI: 10.1016/j.bmc.2010.01.041  1
2010 Abate C, Elenewski J, Niso M, Berardi F, Colabufo NA, Azzariti A, Perrone R, Glennon RA. Interaction of the σ2 receptor ligand PB28 with the human nucleosome: Computational and experimental probes of interaction with the H2A/H2B dimer Chemmedchem. 5: 268-273. PMID 20077462 DOI: 10.1002/cmdc.200900402  1
2009 Abate C, Mosier PD, Berardi F, Glennon RA. A structure-affinity and comparative molecular field analysis of sigma-2 (σ2) receptor ligands Central Nervous System Agents in Medicinal Chemistry. 9: 246-257. PMID 20021358  1
2009 Glennon RA. The enigmatic sigma receptors Central Nervous System Agents in Medicinal Chemistry. 9: 159-160. PMID 20021349 DOI: 10.2174/1871524910909030159  1
2009 Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, et al. Predicting new molecular targets for known drugs. Nature. 462: 175-81. PMID 19881490 DOI: 10.1038/nature08506  1
2009 Young R, Glennon RA. S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats Psychopharmacology. 203: 369-382. PMID 18795268 DOI: 10.1007/s00213-008-1317-2  1
2009 Khorana N, Young R, Glennon RA. Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats Pharmacology Biochemistry and Behavior. 91: 385-392. PMID 18778728 DOI: 10.1016/j.pbb.2008.08.013  1
2009 May JA, Sharif NA, Chen HH, Liao JC, Kelly CR, Glennon RA, Young R, Li JX, Rice KC, France CP. Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]. Pharmacology, Biochemistry, and Behavior. 91: 307-14. PMID 18718483 DOI: 10.1016/j.pbb.2008.07.015  1
2008 Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation. Journal of Medicinal Chemistry. 51: 6808-28. PMID 18847250 DOI: 10.1021/jm800771x  1
2008 Dukat M, Mosier PD, Kolanos R, Roth BL, Glennon RA. Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies. Journal of Medicinal Chemistry. 51: 603-11. PMID 18201064 DOI: 10.1021/jm070910s  1
2008 Young R, Glennon RA. MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice Pharmacology Biochemistry and Behavior. 88: 318-331. PMID 17904622 DOI: 10.1016/j.pbb.2007.09.002  1
2007 Kim JS, Padnya A, Weltzin M, Edmonds BW, Schulte MK, Glennon RA. Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulator Bioorganic and Medicinal Chemistry Letters. 17: 4855-4860. PMID 17604168 DOI: 10.1016/j.bmcl.2007.06.047  1
2007 Dukat M, Wesolowska A, Young R, Glennon RA. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats Pharmacology Biochemistry and Behavior. 87: 203-207. PMID 17540440 DOI: 10.1016/j.pbb.2007.03.008  1
2007 Dukat M, Glennon RA, Young S. MD-354: What is it good for? Cns Drug Reviews. 13: 1-20. PMID 17461887 DOI: 10.1111/j.1527-3458.2007.00002.x  1
2007 Glennon RA, Young R, Dukat M, Chang-Fong J, El-Zahabi M. N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats Pharmacology Biochemistry and Behavior. 86: 477-484. PMID 17307247 DOI: 10.1016/j.pbb.2007.01.007  1
2007 Nyandege A, Kolanos R, Roth BL, Glennon RA. Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 17: 1691-4. PMID 17239595 DOI: 10.1016/j.bmcl.2006.12.089  1
2007 De Oliveira EO, Brandt CA, Da Silveira MAB, Glennon RA. Synthesis of pyrrolidine-substituted benzamides via iodocyclization of β-enaminoesters Tetrahedron Letters. 48: 6393-6396. DOI: 10.1016/j.tetlet.2007.06.166  1
2007 Ablordeppey SY, Glennon RA. Pharmacophore models for σ1 receptor binding Sigma Receptors: Chemistry, Cell Biology and Clinical Implications. 71-98. DOI: 10.1007/978-0-387-36514-5_4  1
2006 Glennon RA, Bondareva T, Young R. α-Ethyltryptamine (α-ET) as a discriminative stimulus in rats Pharmacology Biochemistry and Behavior. 85: 448-453. PMID 17112572 DOI: 10.1016/j.pbb.2006.09.014  1
2006 Young R, Bondareva T, Wesolowska A, Young S, Glennon RA. Effect of the 5-HT6 serotonin antagonist MS-245 on the actions of (-)nicotine Pharmacology Biochemistry and Behavior. 85: 170-177. PMID 16950502 DOI: 10.1016/j.pbb.2006.07.029  1
2006 Kolanos R, Dukat M, Roth BL, Glennon RA. Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 16: 5832-5. PMID 16945532 DOI: 10.1016/j.bmcl.2006.08.068  1
2006 Sikazwe D, Bondarev ML, Dukat M, Rangisetty JB, Roth BL, Glennon RA. Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors. Journal of Medicinal Chemistry. 49: 5217-25. PMID 16913710 DOI: 10.1021/jm060469q  1
2006 Ragab HM, Kim JS, Dukat M, Navarro H, Glennon RA. Aryloxyethylamines: Binding at α7 nicotinic acetylcholine receptors Bioorganic and Medicinal Chemistry Letters. 16: 4283-4286. PMID 16765047 DOI: 10.1016/j.bmcl.2006.05.080  1
2006 Young R, Batkai S, Dukat M, Glennon RA. TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice Pharmacology Biochemistry and Behavior. 84: 62-73. PMID 16750844 DOI: 10.1016/j.pbb.2006.04.006  1
2006 Young R, Rothman RB, Rangisetty JB, Partilla JS, Dukat M, Glennon RA. TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) inhibits the consumption of "snacks" in mice Pharmacology Biochemistry and Behavior. 84: 74-83. PMID 16750261 DOI: 10.1016/j.pbb.2006.04.007  1
2006 Siripurapu U, Kolanos R, Dukat M, Roth BL, Glennon RA. Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 16: 3793-6. PMID 16709453 DOI: 10.1016/j.bmcl.2006.04.094  1
2006 Young R, Bondareva T, Wesolowska A, Glennon RA. Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT) Pharmacology Biochemistry and Behavior. 83: 612-617. PMID 16675002 DOI: 10.1016/j.pbb.2006.03.025  1
2006 Glennon RA. 3-(4-(Tetrahydropyridin-1-yl) butyl) oxindoles as 5-HT 7 receptor Expert Opinion On Therapeutic Patents. 16: 1171-1174. DOI: 10.1517/13543776.16.8.1171  1
2005 Bondareva T, Weso?owska A, Dukat M, Lee M, Young R, Glennon RA. S(+)- and R(-)N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine Pharmacology Biochemistry and Behavior. 82: 531-538. PMID 16337676 DOI: 10.1016/j.pbb.2005.10.008  1
2005 Young R, Khorana N, Bondareva T, Glennon RA. Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA) Pharmacology Biochemistry and Behavior. 82: 404-410. PMID 16253319 DOI: 10.1016/j.pbb.2005.09.010  1
2005 Glennon RA. Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the "Deconstruction - Reconstruction - Elaboration" approach Mini-Reviews in Medicinal Chemistry. 5: 927-940. PMID 16250835 DOI: 10.2174/138955705774329519  1
2005 Pullagurla M, Siripurapu U, Kolanos R, Bondarev ML, Dukat M, Setola V, Roth BL, Glennon RA. Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 5298-302. PMID 16183286 DOI: 10.1016/j.bmcl.2005.08.059  1
2005 Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA. 3-(2-Aminoethyl)pyridine analogs as α4β2 nicotinic cholinergic receptor ligands Bioorganic and Medicinal Chemistry Letters. 15: 4308-4312. PMID 16039854 DOI: 10.1016/j.bmcl.2005.06.053  1
2005 Abate C, Kolanos R, Dukat M, Setola V, Roth BL, Glennon RA. Interaction of chiral MS-245 analogs at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 15: 3510-3. PMID 15990303 DOI: 10.1016/j.bmcl.2005.05.092  1
2005 Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA. 6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand Bioorganic and Medicinal Chemistry Letters. 15: 3237-3240. PMID 15925512 DOI: 10.1002/CHIN.200543161  1
2005 Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA. 6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand Bioorganic and Medicinal Chemistry Letters. 15: 3237-3240. PMID 15925512 DOI: 10.1002/CHIN.200543161  1
2005 Setola V, Dukat M, Glennon RA, Roth BL. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. Molecular Pharmacology. 68: 20-33. PMID 15831837 DOI: 10.1124/mol.104.009266  1
2005 Kolanos R, Siripurapu U, Pullagurla M, Riaz M, Setola V, Roth BL, Dukat M, Glennon RA. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 1987-91. PMID 15808453 DOI: 10.1016/j.bmcl.2005.02.070  1
2005 Kolanos R, Siripurapu U, Pullagurla M, Riaz M, Setola V, Roth BL, Dukat M, Glennon RA. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 1987-91. PMID 15808453 DOI: 10.1016/j.bmcl.2005.02.070  1
2005 Lee M, Rangisetty JB, Pullagurla MR, Dukat M, Setola V, Roth BL, Glennon RA. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 15: 1707-11. PMID 15745826 DOI: 10.1016/j.bmcl.2005.01.031  1
2005 Lee M, Rangisetty JB, Pullagurla MR, Dukat M, Setola V, Roth BL, Glennon RA. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 15: 1707-11. PMID 15745826 DOI: 10.1016/j.bmcl.2005.01.031  1
2005 Pullagurla M, Dukat M, Roth BL, Setola V, Glennon RA. 5-Azatryptamine analogs as h5-HT6 serotonin receptor ligands Medicinal Chemistry Research. 14: 1-18. DOI: 10.1007/s00044-004-0121-8  1
2005 Glennon RA. Binding characteristics of σ2 receptor ligands Revista Brasileira De Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences. 41: 1-12.  1
2004 Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47: 6034-41. PMID 15537358 DOI: 10.1021/jm040082s  1
2004 Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47: 6034-41. PMID 15537358 DOI: 10.1021/jm040082s  1
2004 Pullagurla MR, Westkaemper RB, Glennon RA. Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors Bioorganic and Medicinal Chemistry Letters. 14: 4569-4573. PMID 15357994 DOI: 10.1016/j.bmcl.2004.05.076  1
2004 Pullagurla MR, Westkaemper RB, Glennon RA. Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors Bioorganic and Medicinal Chemistry Letters. 14: 4569-4573. PMID 15357994 DOI: 10.1016/j.bmcl.2004.05.076  0.36
2004 Prisinzano T, Dukat M, Law H, Slassi A, MacLean N, DeLannoy I, Glennon RA. 2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT 1D serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 4697-4699. PMID 15324890 DOI: 10.1016/j.bmcl.2004.06.085  1
2004 Khorana N, Pullagurla MR, Dukat M, Young R, Glennon RA. Stimulus effects of three sulfur-containing psychoactive agents Pharmacology Biochemistry and Behavior. 78: 821-826. PMID 15301941 DOI: 10.1016/j.pbb.2004.05.021  1
2004 Khorana N, Pullagurla MR, Dukat M, Young R, Glennon RA. Stimulus effects of three sulfur-containing psychoactive agents Pharmacology Biochemistry and Behavior. 78: 821-826. PMID 15301941 DOI: 10.1016/j.pbb.2004.05.021  0.44
2004 Pullagurla M, Bondareva T, Young R, Glennon RA. Modulation of the stimulus effects of (+)amphetamine by the 5-HT 6 antagonist MS-245 Pharmacology Biochemistry and Behavior. 78: 263-268. PMID 15219766 DOI: 10.1016/j.pbb.2004.03.017  1
2004 Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA. (+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 14: 3651-4. PMID 15203136 DOI: 10.1016/j.bmcl.2004.05.020  1
2004 Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA. (+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 14: 3651-4. PMID 15203136 DOI: 10.1016/j.bmcl.2004.05.020  1
2004 Khorana N, Pullagurla MR, Young R, Glennon RA. Comparison of the discriminative stimulus effects of 3,4- methylenedioxymethamphetamine (MDMA) and cocaine: Asymmetric generalization Drug and Alcohol Dependence. 74: 281-287. PMID 15194206 DOI: 10.1016/j.drugalcdep.2004.01.005  1
2004 Khorana N, Pullagurla MR, Young R, Glennon RA. Comparison of the discriminative stimulus effects of 3,4- methylenedioxymethamphetamine (MDMA) and cocaine: Asymmetric generalization Drug and Alcohol Dependence. 74: 281-287. PMID 15194206 DOI: 10.1016/j.drugalcdep.2004.01.005  0.44
2004 Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA. Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry. 12: 2545-2552. PMID 15110837 DOI: 10.1016/j.bmc.2004.03.026  1
2004 Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA. Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry. 12: 2545-2552. PMID 15110837 DOI: 10.1016/j.bmc.2004.03.026  0.44
2004 Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. 14: 2279-83. PMID 15081025 DOI: 10.1016/j.bmcl.2004.02.014  1
2004 Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. 14: 2279-83. PMID 15081025 DOI: 10.1016/j.bmcl.2004.02.014  1
2004 Glennon RA, Ismaiel AM, Ablordeppey S, El-Ashmawy M, Fisher JB. Thioxanthene-derived analogs as sigma(1) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14: 2217-20. PMID 15081012 DOI: 10.1016/j.bmcl.2004.02.018  1
2004 Glennon RA, Ismaiel AM, Ablordeppey S, El-Ashmawy M, Fisher JB. Thioxanthene-derived analogs as sigma(1) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14: 2217-20. PMID 15081012 DOI: 10.1016/j.bmcl.2004.02.018  1
2004 Chang-Fong J, Rangisetty JB, Dukat M, Setola V, Raffay T, Roth B, Glennon RA. 1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1961-1964. PMID 15050637 DOI: 10.1016/j.bmcl.2004.01.071  1
2004 Chang-Fong J, Rangisetty JB, Dukat M, Setola V, Raffay T, Roth B, Glennon RA. 1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1961-1964. PMID 15050637 DOI: 10.1016/j.bmcl.2004.01.071  0.36
2004 Glennon RA, Dukat M. α4β2 nACh Receptor pharmacophore models Bioorganic and Medicinal Chemistry Letters. 14: 1841-1844. PMID 15050612 DOI: 10.1016/j.bmcl.2003.07.035  1
2004 Chang-Fong J, Tyacke RJ, Lau A, Westaway J, Hudson AL, Glennon RA. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I2 receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1003-1005. PMID 15013010 DOI: 10.1016/j.bmcl.2003.12.033  1
2004 Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of β-carbolines at imidazoline I2 receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry Letters. 14: 999-1002. PMID 15013009 DOI: 10.1016/j.bmcl.2003.11.078  1
2004 Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of β-carbolines at imidazoline I2 receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry Letters. 14: 999-1002. PMID 15013009 DOI: 10.1016/j.bmcl.2003.11.078  0.32
2004 Glennon RA. Medicinal Chemistry of α4β2 Nicotinic Cholinergic Receptor Ligands Progress in Medicinal Chemistry. 42: 55-123. PMID 15003719 DOI: 10.1016/S0079-6468(04)42002-5  1
2004 Glennon RA, Dukat M, Liao L. Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models. Current Topics in Medicinal Chemistry. 4: 631-44. PMID 14965299  0.64
2004 Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of an imidazopyridoindole at imidazoline I2 receptors Bioorganic and Medicinal Chemistry Letters. 14: 527-529. PMID 14698196 DOI: 10.1016/j.bmcl.2003.09.092  1
2004 Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of an imidazopyridoindole at imidazoline I2 receptors Bioorganic and Medicinal Chemistry Letters. 14: 527-529. PMID 14698196 DOI: 10.1016/j.bmcl.2003.09.092  0.32
2004 Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA. 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors. Bioorganic & Medicinal Chemistry Letters. 14: 523-6. PMID 14698195 DOI: 10.1016/j.bmcl.2003.10.033  1
2004 Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA. 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors. Bioorganic & Medicinal Chemistry Letters. 14: 523-6. PMID 14698195 DOI: 10.1016/j.bmcl.2003.10.033  1
2004 Glennon RA, Dukat M, Liao L. Musings on αβ2 nicotinic acetylcholine (nACh) receptor pharmacophore models Current Topics in Medicinal Chemistry. 4: 631-644. DOI: 10.2174/1568026043451122  1
2004 Glennon RA, Dukat M, Liao L. Musings on αβ2 nicotinic acetylcholine (nACh) receptor pharmacophore models Current Topics in Medicinal Chemistry. 4: 631-644. DOI: 10.2174/1568026043451122  0.64
2004 Giorgioni G, Piergentili A, Glennon RA. 14th Camerino Noordwijkerhout Symposium: (1978-2003, The Silver Symposium) Ongoing Progress in the Receptor Chemistry - September 7-11, 2003, Camerino, Italy. Guest editorial Medicinal Chemistry Research. 13: 127-130. DOI: 10.1007/s00044-004-0018-6  1
2004 Glennon RA. Nicotine and pain Medicinal Chemistry Research. 13: 74-77. DOI: 10.1007/s00044-004-0011-0  1
2004 Giorgioni G, Piergentili A, Glennon RA. Guest editorial Medicinal Chemistry Research. 13: 1. DOI: 10.1007/s00044-004-0001-2  1
2003 Tyacke RJ, Lau A, Grella B, Glennon RA, Nutt DJ, Hudson AL. Investigation of the Affinities of Two New β-Carbolines for Rat Brain Imidazoline2 Receptors Annals of the New York Academy of Sciences. 1009: 361-363. PMID 15028612 DOI: 10.1196/annals.1304.047  1
2003 Tyacke RJ, Lau A, Grella B, Glennon RA, Nutt DJ, Hudson AL. Investigation of the Affinities of Two New β-Carbolines for Rat Brain Imidazoline2 Receptors Annals of the New York Academy of Sciences. 1009: 361-363. PMID 15028612 DOI: 10.1196/annals.1304.047  0.32
2003 Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. 482: 335-7. PMID 14660041 DOI: 10.1016/j.ejphar.2003.09.059  1
2003 Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. 482: 335-7. PMID 14660041 DOI: 10.1016/j.ejphar.2003.09.059  1
2003 Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA. Binding of β-carbolines at 5-HT2 serotonin receptors Bioorganic and Medicinal Chemistry Letters. 13: 4421-4425. PMID 14643338 DOI: 10.1016/j.bmcl.2003.09.027  1
2003 Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7  1
2003 Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7  1
2003 Glennon RA, Daoud MK, Dukat MS, Teitler M, Herrick-Davis K, Purohit A, Syed H. Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: A QSAR study Bioorganic and Medicinal Chemistry. 11: 4449-4454. PMID 13129581 DOI: 10.1016/S0968-0896(03)00488-7  1
2003 Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior. 75: 845-52. PMID 12957227 DOI: 10.1016/S0091-3057(03)00159-X  1
2003 Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. The Journal of Pharmacology and Experimental Therapeutics. 307: 138-45. PMID 12954796 DOI: 10.1124/jpet.103.053975  1
2003 Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. The Journal of Pharmacology and Experimental Therapeutics. 307: 138-45. PMID 12954796 DOI: 10.1124/jpet.103.053975  1
2003 Pullagurla MR, Dukat M, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates. Bioorganic & Medicinal Chemistry Letters. 13: 3355-9. PMID 12951125  0.76
2003 Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors. Journal of Medicinal Chemistry. 46: 3930-7. PMID 12930153 DOI: 10.1021/jm030080s  1
2003 Bondarev ML, Bondareva TS, Young R, Glennon RA. Behavioral and biochemical investigations of bupropion metabolites. European Journal of Pharmacology. 474: 85-93. PMID 12909199 DOI: 10.1016/S0014-2999(03)02010-7  1
2003 Peddi S, Roth BL, Glennon RA, Westkaemper RB. Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor. Bioorganic & Medicinal Chemistry Letters. 13: 2565-8. PMID 12852967 DOI: 10.1016/S0960-894X(03)00504-3  1
2003 Glennon RA. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). Journal of Medicinal Chemistry. 46: 2795-812. PMID 12825922 DOI: 10.1021/jm030030n  1
2003 Dukat M, Glennon RA. Epibatidine: impact on nicotinic receptor research. Cellular and Molecular Neurobiology. 23: 365-78. PMID 12825833 DOI: 10.1023/A:1023692705700  1
2003 Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Molecular Pharmacology. 63: 1223-9. PMID 12761331 DOI: 10.1124/mol.63.6.1223  1
2003 Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA. Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG). Bioorganic & Medicinal Chemistry Letters. 13: 1119-23. PMID 12643925 DOI: 10.1016/S0960-894X(03)00044-1  1
2003 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors. Bioorganic & Medicinal Chemistry Letters. 13: 733-5. PMID 12639569 DOI: 10.1016/S0960-894X(02)01031-4  1
2003 Khorana N, Purohit A, Herrick-Davis K, Teitler M, Glennon RA. gamma-Carbolines: binding at 5-HT5A serotonin receptors. Bioorganic & Medicinal Chemistry. 11: 717-22. PMID 12538001 DOI: 10.1016/S0968-0896(02)00527-8  1
2003 Pullagurla MR, Dukat MS, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N 1-benzenesulfonylskatole: Novel 5-HT6 receptor ligand templates Bioorganic and Medicinal Chemistry Letters. 13: 3355-3359. DOI: 10.1016/S0960-894X(03)00612-7  1
2003 Pullagurla MR, Dukat MS, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N 1-benzenesulfonylskatole: Novel 5-HT6 receptor ligand templates Bioorganic and Medicinal Chemistry Letters. 13: 3355-3359. DOI: 10.1016/S0960-894X(03)00612-7  0.76
2002 Bondareva TS, Young R, Glennon RA. Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine. Pharmacology, Biochemistry, and Behavior. 74: 157-62. PMID 12376163 DOI: 10.1016/S0091-3057(02)00963-2  1
2002 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding. Journal of Medicinal Chemistry. 45: 4724-31. PMID 12361399 DOI: 10.1021/jm020188s  1
2002 Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA. (-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine. Bioorganic & Medicinal Chemistry Letters. 12: 3005-7. PMID 12270194 DOI: 10.1016/S0960-894X(02)00614-5  1
2002 Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA. A comparison of the binding of three series of nicotinic ligands. Bioorganic & Medicinal Chemistry Letters. 12: 1989-92. PMID 12113825 DOI: 10.1016/S0960-894X(02)00298-6  1
2002 Ablordeppey SY, Fischer JB, Law H, Glennon RA. Probing the proposed phenyl-A region of the sigma-1 receptor. Bioorganic & Medicinal Chemistry. 10: 2759-65. PMID 12057665 DOI: 10.1016/S0968-0896(02)00096-2  1
2002 Westkaemper RB, Glennon RA. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands. Current Topics in Medicinal Chemistry. 2: 575-98. PMID 12052195  1
2002 Glennon RA, Metwally K, Dukat M, Ismaiel AM, De los Angeles J, Herndon J, Teitler M, Khorana N. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists. Current Topics in Medicinal Chemistry. 2: 539-58. PMID 12052193 DOI: 10.1016/B978-008055232-3.61983-X  1
2002 Young R, Glennon RA. Nicotine and bupropion share a similar discriminative stimulus effect. European Journal of Pharmacology. 443: 113-8. PMID 12044800 DOI: 10.1016/S0014-2999(02)01554-6  1
2002 Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Journal of Medicinal Chemistry. 45: 1656-64. PMID 11931619 DOI: 10.1021/jm010354g  1
2002 Glennon RA, Young R, Rangisetty JB. Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline. Pharmacology, Biochemistry, and Behavior. 72: 379-87. PMID 11900809 DOI: 10.1016/S0091-3057(01)00768-7  1
2002 Glennon RA, Young R. Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats. Pharmacology, Biochemistry, and Behavior. 72: 307-11. PMID 11900801 DOI: 10.1016/S0091-3057(01)00770-5  1
2002 Dukat M, Young R, Glennon RA. Effect of PMA optical isomers and 4-MTA in PMMA-trained rats. Pharmacology, Biochemistry, and Behavior. 72: 299-305. PMID 11900800 DOI: 10.1016/S0091-3057(01)00776-6  1
2002 Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European Journal of Pharmacology. 435: 171-80. PMID 11821023 DOI: 10.1016/S0014-2999(01)01570-9  1
2002 Young R, Glennon RA. The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine. Pharmacology, Biochemistry, and Behavior. 71: 205-13. PMID 11812524 DOI: 10.1016/S0091-3057(01)00666-9  1
2002 Chang-Fong J, Addo J, Dukat M, Smith C, Mitchell NA, Herrick-Davis K, Teitler M, Glennon RA. Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 12: 155-8. PMID 11755343 DOI: 10.1016/S0960-894X(01)00713-2  1
2002 Glennon RA. A final editorial Medicinal Chemistry Research. 11: v.  1
2001 Hong SS, Young R, Glennon RA. Discriminative stimulus properties of alpha-ethyltryptamine optical isomers. Pharmacology, Biochemistry, and Behavior. 70: 311-6. PMID 11701202 DOI: 10.1016/S0091-3057(01)00605-0  1
2001 Rangisetty JB, Dukat M, Dowd CS, Herrick-Davis K, DuPre A, Gadepalli S, Teitler M, Kelley CR, Sharif NA, Glennon RA. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. Journal of Medicinal Chemistry. 44: 3283-91. PMID 11563927 DOI: 10.1021/jm0100739  1
2001 Husbands SM, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, Nutt DJ, Lewis JW, Hudson AL. beta-carboline binding to imidazoline receptors. Drug and Alcohol Dependence. 64: 203-8. PMID 11543990 DOI: 10.1016/S0376-8716(01)00123-5  1
2001 Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA. Pharmacology, Biochemistry, and Behavior. 69: 261-7. PMID 11420094 DOI: 10.1016/S0091-3057(01)00530-5  1
2001 Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation. Bioorganic & Medicinal Chemistry Letters. 11: 1599-603. PMID 11412989 DOI: 10.1016/S0960-894X(01)00291-8  1
2001 Prisinzano T, Law H, Dukat M, Slassi A, MaClean N, Demchyshyn L, Glennon RA. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands. Bioorganic & Medicinal Chemistry. 9: 613-9. PMID 11310595 DOI: 10.1016/S0968-0896(00)00275-3  1
2001 Runyon SP, Savage JE, Taroua M, Roth BL, Glennon RA, Westkaemper RB. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Bioorganic & Medicinal Chemistry Letters. 11: 655-8. PMID 11266163 DOI: 10.1016/S0960-894X(01)00023-3  1
2001 Westkaemper RB, Runyon SP, Savage JE, Roth BL, Glennon RA. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor. Bioorganic & Medicinal Chemistry Letters. 11: 563-6. PMID 11229772 DOI: 10.1016/S0960-894X(01)00010-5  1
2001 Prisinzano T, Law H, Slassi A, Maclean N, Demchyshyn L, Glennon RA. QSAR studies on 2-(benzyl)imidazoline analogs as h5-HT1D/1B serotonin receptor ligands Medicinal Chemistry Research. 10: 309-317.  1
2000 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Chain-lengthened and imidazoline analogues of nicotine. Bioorganic & Medicinal Chemistry Letters. 10: 2665-8. PMID 11128647 DOI: 10.1016/S0960-894X(00)00541-2  1
2000 Tsai Y, Dukat M, Slassi A, MacLean N, Demchyshyn L, Savage JE, Roth BL, Hufesein S, Lee M, Glennon RA. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 10: 2295-9. PMID 11055342 DOI: 10.1016/S0960-894X(00)00453-4  1
2000 Ablordeppey SY, Fischer JB, Glennon RA. Is a nitrogen atom an important pharmacophoric element in sigma ligand binding? Bioorganic & Medicinal Chemistry. 8: 2105-11. PMID 11003156 DOI: 10.1016/S0968-0896(00)00148-6  1
2000 Hellberg M, Stubbins JF, Glennon RA. A preliminary investigation of mesoionic xanthine analogues as inhibitors of platelet aggregation. Bioorganic & Medicinal Chemistry. 8: 1917-23. PMID 11003136 DOI: 10.1016/S0968-0896(00)00123-1  1
2000 Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists Journal of Medicinal Chemistry. 43: 3074-3084. PMID 10956215 DOI: 10.1021/jm9906062  1
2000 Glennon RA, Dukat M, Grella B, Hong SS, Costantino L, Teitler M, Smith C, Egan C, Davis K, Mattson MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5- HT(1A)), dopamine (D2) and benzodiazepine receptors Drug and Alcohol Dependence. 60: 121-132. PMID 10940539 DOI: 10.1016/S0376-8716(99)00148-9  1
2000 Dukat M, Young R, Darmani NN, Ahmed B, Glennon RA. The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay Psychopharmacology. 150: 200-207. PMID 10907673 DOI: 10.1007/s002130000410  1
2000 Young R, Glennon RA. Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats Pharmacology Biochemistry and Behavior. 66: 489-494. PMID 10899360 DOI: 10.1016/S0091-3057(00)00173-8  1
2000 Glennon RA, Young R. MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin Pharmacology Biochemistry and Behavior. 66: 483-488. PMID 10899359 DOI: 10.1016/S0091-3057(00)00174-X  1
2000 Kristiansen K, Kroeze WK, Willins DL, Gelber EI, Savage JE, Glennon RA, Roth BL. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. The Journal of Pharmacology and Experimental Therapeutics. 293: 735-46. PMID 10869371  1
2000 Glennon RA, Young R. (+)Amphetamine-stimulus generalization to an herbal ephedrine product Pharmacology Biochemistry and Behavior. 65: 655-658. PMID 10764918 DOI: 10.1016/S0091-3057(99)00238-5  1
2000 Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. Journal of Medicinal Chemistry. 43: 1011-8. PMID 10715164 DOI: 10.1021/jm990550b  1
2000 Glennon RA, Dukat M. Central nicotinic receptor ligands and pharmacophores Pharmacochemistry Library. 31: 103-114. DOI: 10.1016/S0165-7208(00)80006-9  1
2000 Lee M, Rangisetty JB, Dukat M, Slassi A, Maclean N, Lee DKH, Glennon RA. 5-HT6 serotonin receptor binding affinities of N1-benzenesulfonyl and related tryptamines Medicinal Chemistry Research. 10: 230-242.  1
1999 Young R, Bondarev M, Glennon RA. An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats Drug and Alcohol Dependence. 57: 1-6. PMID 10617308 DOI: 10.1016/S0376-8716(99)00052-6  1
1999 Young R, Dukat M, Malmusi L, Glennon RA. Stimulus properties of PMMA: Effect of optical isomers and conformational restriction Pharmacology Biochemistry and Behavior. 64: 449-453. PMID 10515329 DOI: 10.1016/S0091-3057(99)00060-X  1
1999 Glennon RA. Arylalkylamine drugs of abuse: An overview of drug discrimination studies Pharmacology Biochemistry and Behavior. 64: 251-256. PMID 10515299 DOI: 10.1016/S0091-3057(99)00045-3  1
1999 Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. European Journal of Pharmacology. 380: R5-7. PMID 10513561 DOI: 10.1016/S0014-2999(99)00525-7  1
1999 Flammia D, Dukat M, Damaj MI, Martin B, Glennon RA. Lobeline: Structure-affinity investigation of nicotinic acetylcholinergic receptor binding Journal of Medicinal Chemistry. 42: 3726-3731. PMID 10479304 DOI: 10.1021/jm990286m  1
1999 Nelson DL, Lucaites VL, Wainscott DB, Glennon RA. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 1-6. PMID 9933142  1
1999 Westkaemper RB, Hyde EG, Choudhary MS, Khan N, Gelbar EI, Glennon RA, Roth BL. Engineering a region of bulk tolerance in the 5-ht(2a) receptor European Journal of Medicinal Chemistry. 34: 441-447. DOI: 10.1016/S0223-5234(99)80094-4  1
1999 Cheng YX, Dukat M, Dowd M, Fiedler W, Martin B, Damaj MI, Glennon RA. Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors European Journal of Medicinal Chemistry. 34: 177-190. DOI: 10.1016/S0223-5234(99)80051-8  1
1999 Dukat M, Dowd M, Damaj MI, Martin B, El-Zahabi MA, Glennon RA. Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands European Journal of Medicinal Chemistry. 34: 31-40. DOI: 10.1016/S0223-5234(99)80038-5  1
1999 Hong S, Dukat M, Teitler M, Egan C, Dupre A, Herrick-Davis K, Glennon RA. 5,8-Dimethoxyharmalan: Actions at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 374-388.  1
1999 Khorana N, Bondarev M, Dukat M, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. Binding of spiperone analogs at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 657-667.  1
1999 Glennon RA, Bondarev M, Roth B. 5-HT6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation Medicinal Chemistry Research. 9: 108-117.  1
1998 Young R, Glennon RA. Discriminative stimulus effects of S(-)-methcathinone (CAT): A potent stimulant drug of abuse Psychopharmacology. 140: 250-256. PMID 9877004 DOI: 10.1007/s002130050765  1
1998 Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA. Spiperone: Influence of spiro ring substituents on 5-HT(2A) serotonin receptor binding Journal of Medicinal Chemistry. 41: 5084-5093. PMID 9836624 DOI: 10.1021/jm980452a  1
1998 Young R, Gabryszuk M, Glennon RA. (-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects Pharmacology Biochemistry and Behavior. 61: 169-173. PMID 9738532 DOI: 10.1016/S0091-3057(98)00044-6  1
1998 Young R, Glennon RA. Discriminative stimulus properties of (-)ephedrine Pharmacology Biochemistry and Behavior. 60: 771-775. PMID 9678664 DOI: 10.1016/S0091-3057(98)00055-0  1
1998 Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA. Investigation of hallucinogenic and related β-carbolines Drug and Alcohol Dependence. 50: 99-107. PMID 9649961 DOI: 10.1016/S0376-8716(97)00163-4  1
1998 Law H, Dukat M, Teitler M, Lee DKH, Mazzocco L, Kamboj R, Rampersad V, Prisinzano T, Glennon RA. Benzylimidazolines as h5-HT(1B/1D) serotonin receptor ligands: A structure-affinity investigation Journal of Medicinal Chemistry. 41: 2243-2251. PMID 9632357 DOI: 10.1021/jm970513p  1
1998 Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M. Agonist activity of LSD and lisuride at cloned 5HT(2A) and 5HT(2C) receptors Psychopharmacology. 136: 409-414. PMID 9600588 DOI: 10.1007/s002130050585  1
1998 Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. The Journal of Pharmacology and Experimental Therapeutics. 284: 1058-65. PMID 9495867  1
1998 Ablordeppey SY, El-Ashmawy M, Fischer JB, Glennon RA. A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand European Journal of Medicinal Chemistry. 33: 625-633. DOI: 10.1016/S0223-5234(98)80021-4  1
1998 Bondarev M, Iwamura T, Hynd D, Mazzocco L, Lee DKH, Dukat M, Glennon RA. Aryloxyethylamines as h5-HT(1D) serotonin receptor ligands Medicinal Chemistry Research. 8: 333-342.  1
1997 Ismaiel AM, Dukat M, Law H, Kamboj R, Fan E, Lee DKH, Mazzocco L, Buekschkens D, Teitler M, Pierson ME, Glennon RA. 2-(1-naphthyloxy)ethylamines with enhanced affinity for human 5-HT(1Dβ) (h5-HT(1B)) serotonin receptors Journal of Medicinal Chemistry. 40: 4415-4419. PMID 9435911 DOI: 10.1021/jm970507t  1
1997 Dal Cason TA, Young R, Glennon RA. Cathinone: An investigation of several N-alkyl and methylenedioxy-substituted analogs Pharmacology Biochemistry and Behavior. 58: 1109-1116. PMID 9408221 DOI: 10.1016/S0091-3057(97)00323-7  1
1997 Glennon RA, Young R, Dukat M, Cheng Y. Initial characterization of PMMA as a discriminative stimulus Pharmacology Biochemistry and Behavior. 57: 151-158. PMID 9164566 DOI: 10.1016/S0091-3057(96)00306-1  1
1997 Young R, Glennon RA. Cocaine - Stimulus generalization to MDA optical isomores: A reevaluation Pharmacology Biochemistry and Behavior. 57: 115-118. PMID 9164561 DOI: 10.1016/S0091-3057(96)00352-8  1
1997 Young R, Darmani NA, Elder EL, Dumas D, Glennon RA. Clobenzorex: Evidence for amphetamine-like behavioral actions Pharmacology Biochemistry and Behavior. 56: 311-316. PMID 9050090 DOI: 10.1016/S0091-3057(96)00329-2  1
1997 Teitler M, Scheick C, Howard P, Sullivan JE, Iwamura T, Glennon RA. 5-HT5A serotonin receptor binding: A preliminary structure-affinity investigation Medicinal Chemistry Research. 7: 207-218.  1
1996 Dukat M, Abdel-Rahman AA, Ismaiel AM, Ingher S, Teitler M, Gyermek L, Glennon RA. Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors Journal of Medicinal Chemistry. 39: 4017-4026. PMID 8831767 DOI: 10.1021/jm9603936  1
1996 Young R, Glennon RA. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA Journal of Pharmacology and Experimental Therapeutics. 276: 594-601. PMID 8632326  1
1996 Glennon RA, Dukat M, Westkaemper RB, Ismaiel AM, Izzarelli DG, Parker EM. The binding of propranolol at 5-hydroxytryptamine1Dβ T355N mutant receptors may involve formation of two hydrogen bonds to asparagine Molecular Pharmacology. 49: 198-206. PMID 8569707  1
1996 Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhit S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C. Binding of O-alkyl derivatives of serotonin at human 5-HT1Dβ receptors Journal of Medicinal Chemistry. 39: 314-322. PMID 8568822 DOI: 10.1021/jm950498t  1
1996 Dukat M, Fiedler W, Dumas D, Damaj I, Martin BR, Rosecrans JA, James JR, Glennon RA. Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation European Journal of Medicinal Chemistry. 31: 875-888. DOI: 10.1016/S0223-5234(97)89850-9  1
1996 Imad Damaj M, Glassco W, Dukat M, May EL, Glennon RA, Martin BR. Pharmacology of novel nicotinic analogs Drug Development Research. 38: 177-187. DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<177::AID-DDR6>3.0.CO;2-J  1
1996 Malmusi L, Dukat M, Young R, Teitler M, Darmani NA, Ahmad B, Smith C, Glennon RA. 1,2,3,4-Tetrahydroisoquinoline analogs of phenylalkylamine stimulants and hallucinogens Medicinal Chemistry Research. 6: 400-411.  1
1996 Ismaiel AM, Dukat M, Nelson DL, Lucaites VL, Glennon RA. Binding of N2-substituted pyrido[4,3-b]indole analogs of spiperone at human 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors Medicinal Chemistry Research. 6: 197-211.  1
1996 Glennon RA, Dukat M. Nicotine receptor ligands Medicinal Chemistry Research. 6: 465-486.  1
1996 Malmusi L, Dukat M, Young R, Teitler M, Darmani NA, Ahmad B, Smith C, Glennon RA. 1,2,3,4-Tetrahydroisoquinoline and related analogs of the phenylalkylamine designer drug MDMA Medicinal Chemistry Research. 6: 412-426.  1
1996 Iwamura T, Casey CT, Young R, Dukat M, Teitler M, Fadden JSP, Glennon RA. 4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance Medicinal Chemistry Research. 6: 593-601.  1
1995 Ismaiel AM, Arruda K, Teitler M, Glennon RA. Ketanserin analogues: The effect of structural modification on 5-HT2 serotonin receptor binding Journal of Medicinal Chemistry. 38: 1196-1202. PMID 7707322  1
1995 Choudhary MS, Sachs N, Uluer A, Glennon RA, Westkaemper RB, Roth BL. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Molecular Pharmacology. 47: 450-7. PMID 7700242  1
1995 Glennon RA, Young R, Martin BR, Dal Cason TA. Methcathinone ("cat"): An enantiomeric potency comparison Pharmacology, Biochemistry and Behavior. 50: 601-606. PMID 7617707 DOI: 10.1016/0091-3057(94)00348-3  1
1994 Westkaemper RB, Glennon RA. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors Nida Research Monograph. 146: 263-283. PMID 8742803  1
1994 Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB. Structural features important for sigma 1 receptor binding. Journal of Medicinal Chemistry. 37: 1214-9. PMID 8164264  1
1994 Glennon RA, Hong SS, Dukat M, Teitler M, Davis K. 5-(Nonyloxy)tryptamine: A novel high-affinity 5-HTIDβ serotonin receptor agonist Journal of Medicinal Chemistry. 37: 2828-2830. PMID 8071931 DOI: 10.1021/JM00044A001  1
1994 Glennon RA, Dukat M, El-Bermawy M, Law H, De Los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines Journal of Medicinal Chemistry. 37: 1929-1935. PMID 8027974  1
1994 Carroll FI, Glennon RA, Johnson MR, Teitler M, Zimmerman DM. Hallucinogenic agents: Drugs of abuse as neurochemical tools Nida Research Monograph Series. 94-98.  1
1994 Glennon RA. Hallucinogens: An update. Summary Nida Research Monograph Series. 298-301.  1
1993 Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, Glennon RA. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist Journal of Medicinal Chemistry. 36: 2519-2525. PMID 8355253 DOI: 10.1021/JM00069A010  1
1993 Glennon RA, Young R, Herndon JL. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs Pharmacology, Biochemistry and Behavior. 45: 865-869. PMID 8105490 DOI: 10.1016/0091-3057(93)90133-E  1
1992 Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. Journal of Medicinal Chemistry. 35: 734-40. PMID 1542100 DOI: 10.1021/JM00082A014  1
1992 Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA. Ketanserin analogues: Structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding Journal of Medicinal Chemistry. 35: 4903-4910. PMID 1479590 DOI: 10.1021/JM00104A017  1
1992 Herndon JL, Pierson ME, Glennon RA. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine Pharmacology, Biochemistry and Behavior. 43: 739-748. PMID 1333084 DOI: 10.1016/0091-3057(92)90403-3  1
1991 Glennon RA, Smith JD, Ismaiel AM, el-Ashmawy M, Battaglia G, Fischer JB. Identification and exploitation of the sigma-opiate pharmacophore. Journal of Medicinal Chemistry. 34: 1094-8. PMID 1848295 DOI: 10.1021/JM00107A033  1
1991 Westkaemper RB, Glennon RA. Approaches to molecular modeling studies and specific application to serotonin ligands and receptors Pharmacology, Biochemistry and Behavior. 40: 1019-1031. PMID 1816556 DOI: 10.1016/0091-3057(91)90122-I  1
1991 Glennon RA, Yousif MY, Ismaiel AM, el-Ashmawy MB, Herndon JL, Fischer JB, Server AC, Howie KJ. Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands. Journal of Medicinal Chemistry. 34: 3360-5. PMID 1662725 DOI: 10.1021/JM00116A003  1
1991 Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA. Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity. Journal of Medicinal Chemistry. 34: 2633-8. PMID 1652026 DOI: 10.1021/JM00112A043  1
1990 Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Drug and Alcohol Dependence. 26: 127-35. PMID 1978707 DOI: 10.1016/0376-8716(90)90119-Y  1
1990 Glennon RA, Battaglia G, Smith JD. (-)PPAP: A new and selective ligand for sigma binding sites Pharmacology, Biochemistry and Behavior. 37: 557-559. PMID 1965044 DOI: 10.1016/0091-3057(90)90027-F  1
1989 Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, Poklis A. Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood. Journal of Chromatography. 490: 59-69. PMID 2760158 DOI: 10.1016/S0378-4347(00)82761-9  1
1989 Fitzgerald RL, Blanke RV, Rosecrans JA, Glennon RA. Stereochemistry of the metabolism of MDMA to MDA. Life Sciences. 45: 295-301. PMID 2569654 DOI: 10.1016/0024-3205(89)90138-0  1
1989 Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis. Psychopharmacology. 98: 495-9. PMID 2505289 DOI: 10.1007/BF00441948  1
1987 Young R, Glennon RA, Dewey WL. Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus. Psychopharmacology. 93: 494-7. PMID 2893416 DOI: 10.1007/BF00207241  1
1987 Rosecrans JA, Glennon RA. The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice. Pharmacology, Biochemistry, and Behavior. 28: 39-42. PMID 2889221 DOI: 10.1016/0091-3057(87)90008-6  1
1987 Glennon RA, Little PJ, Rosecrans JA, Yousif M. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice. Pharmacology, Biochemistry, and Behavior. 26: 425-6. PMID 2883666 DOI: 10.1016/0091-3057(87)90141-9  1
1986 Rasmussen K, Glennon RA, Aghajanian GK. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity. European Journal of Pharmacology. 132: 79-82. PMID 3816969 DOI: 10.1016/0014-2999(86)90014-2  1
1986 Young R, Rosecrans JA, Glennon RA. Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine. Pharmacology, Biochemistry, and Behavior. 25: 1207-10. PMID 3809222 DOI: 10.1016/0091-3057(86)90113-9  1
1986 Young R, Glennon RA, Brase DA, Dewey WL. Potencies of diazepam metabolites in rats trained to discriminate diazepam. Life Sciences. 39: 17-20. PMID 3088348 DOI: 10.1016/0024-3205(86)90432-7  1
1984 Aceto MD, Rosecrans JA, Young R, Glennon RA. Similarity between (+)-amphetamine and amfonelic acid. Pharmacology, Biochemistry, and Behavior. 20: 635-7. PMID 6728880 DOI: 10.1016/0091-3057(84)90316-2  1
1984 Schechter MD, Rosecrans JA, Glennon RA. Comparison of behavioral effects of cathinone, amphetamine and apomorphine. Pharmacology, Biochemistry, and Behavior. 20: 181-4. PMID 6718445 DOI: 10.1016/0091-3057(84)90238-7  1
1984 Shannon M, Battaglia G, Glennon RA, Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA) European Journal of Pharmacology. 102: 23-29. PMID 6479216 DOI: 10.1016/0014-2999(84)90333-9  1
1984 Glennon RA, Schechter MD, Rosecrans JA. Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modifications. Pharmacology, Biochemistry, and Behavior. 21: 1-3. PMID 6463083 DOI: 10.1016/0091-3057(84)90121-7  1
1984 Young R, Glennon RA, Dewey WL. Stereoselective stimulus effects of 3-methylflunitrazepam and pentobarbital. Life Sciences. 34: 1977-83. PMID 6328149 DOI: 10.1016/0024-3205(84)90129-2  1
1984 Glennon RA, Tejani-Butt SM, Padgett W, Daly JW. Mesoionic xanthine analogues: antagonists of adenosine receptors. Journal of Medicinal Chemistry. 27: 1364-7. PMID 6090665  1
1983 Glennon RA, Young R, Rosecrans JA. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. European Journal of Pharmacology. 91: 189-96. PMID 6617740 DOI: 10.1016/0014-2999(83)90464-8  1
1983 Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines. European Journal of Pharmacology. 86: 453-9. PMID 6572591 DOI: 10.1016/0014-2999(83)90196-6  1
1983 Young R, Rosecrans JA, Glennon RA. Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105. Psychopharmacology. 80: 156-60. PMID 6410445 DOI: 10.1007/BF00427960  1
1983 Glennon RA, Rosecrans JA, Young R. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Medicinal Research Reviews. 3: 289-340. PMID 6350763 DOI: 10.1002/MED.2610030305  1
1982 Young R, Rosecrans JA, Glennon RA. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD. Life Sciences. 30: 2057-62. PMID 7109835 DOI: 10.1016/0024-3205(82)90446-5  1
1982 Glennon RA, Young R, Rosecrans JA. A comparison of the behavioral effects of DOM homologs. Pharmacology, Biochemistry, and Behavior. 16: 557-9. PMID 7071089 DOI: 10.1016/0091-3057(82)90414-2  1
1982 Glennon RA, Young R, Rosecrans JA. Discriminative stimulus properties of DOM and several molecular modifications. Pharmacology, Biochemistry, and Behavior. 16: 553-6. PMID 7071088 DOI: 10.1016/0091-3057(82)90413-0  1
1982 Glennon RA, Rosecrans JA. Indolealkylamine and phenalkylamine hallucinogens: a brief overview. Neuroscience and Biobehavioral Reviews. 6: 489-97. PMID 6757811 DOI: 10.1016/0149-7634(82)90030-6  1
1981 Glennon RA, Rosecrans JA, Young R. Behavioral properties of psychoactive phenylisopropylamines in rats. European Journal of Pharmacology. 76: 353-60. PMID 7327208 DOI: 10.1016/0014-2999(81)90106-0  1
1981 Glennon RA, Rosecrans JA. Speculations on the mechanism of action of hallucinogenic indolealkylamines. Neuroscience and Biobehavioral Reviews. 5: 197-207. PMID 7022271 DOI: 10.1016/0149-7634(81)90002-6  1
1980 Glennon RA, Liebowitz SM, Leming-Doot D, Rosecrans JA. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities. Journal of Medicinal Chemistry. 23: 990-4. PMID 7411554 DOI: 10.1021/JM00183A006  1
1980 Glennon RA, Schubert E, Jacyno JM, Rosecrans JA. Studies on several 7-substituted N,N-dimethyltryptamines. Journal of Medicinal Chemistry. 23: 1222-6. PMID 6779006 DOI: 10.1021/JM00185A014  1
1980 Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities. Psychopharmacology. 68: 155-8. PMID 6776558 DOI: 10.1007/BF00432133  1
1979 Glennon RA, Gessner PK, Godse DD, Kline BJ. Bufotenine esters Journal of Medicinal Chemistry. 22: 1414-1416. PMID 533890 DOI: 10.1021/jm00197a025  1
1979 Rosecrans JA, Glennon RA. Drug-induced cues in studying mechanisms of drug action. Neuropharmacology. 18: 981-9. PMID 530379 DOI: 10.1016/0028-3908(79)90162-X  1
1979 Glennon RA, Gessner PK. Serotonin receptor binding affinities of tryptamine analogues Journal of Medicinal Chemistry. 22: 428-432. PMID 430481 DOI: 10.1021/JM00190A014  1
1979 Glennon RA, Rosecrans JA, Young R, Gaines J. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus. Life Sciences. 24: 993-7. PMID 286864 DOI: 10.1016/0024-3205(79)90317-5  1
1974 Coburn RA, Glennon RA, Chmielewicz ZF. Mesoionic purinone analogs. 7. In vitro antibacterial activity of mesoionic1,3,4-thiadiazolo[3,2-a]pyrimidme-5,7-diones Journal of Medicinal Chemistry. 17: 1025-1027. PMID 4213245  1
1973 Coburn RA, Glennon RA. Mesoionic purinone analogs. IV: Synthesis and in vitro antibacterial properties of mesoionic thiazolo[3,2 α]pyrimidin 5,7 diones and mesoionic 1,3,4 thiadiazolo[3,2 α]pyrimidin 5,7 diones Journal of Pharmaceutical Sciences. 62: 1785-1789. PMID 4202220 DOI: 10.1002/JPS.2600621110  1
Show low-probability matches.